Latest Articles
Naga Munchetty opens up about extremely painful health condition that took doctors years to diagnose - AOL.com
Naga Munchetty opens up about extremely painful health condition that took doctors years to diagnose AOL.com
Published: April 15, 2026, 11:54 a.m.
Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression - The Manila Times
Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression The Manila Times
Published: April 15, 2026, 11:45 a.m.
Call for Suffolk Women's Health Hub as government launches new strategy - Ipswich.co.uk
Call for Suffolk Women's Health Hub as government launches new strategy Ipswich.co.uk
Published: April 15, 2026, 11:32 a.m.
Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression - GlobeNewswire
Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression GlobeNewswire
Published: April 15, 2026, 11:30 a.m.
EXCLUSIVE: Penny Stock Medicus Pharma Findings Support Potential In Women's Health Pipeline - Benzinga
EXCLUSIVE: Penny Stock Medicus Pharma Findings Support Potential In Women's Health Pipeline Benzinga
Published: April 15, 2026, 11:16 a.m.
Women's voices to be at the heart of renewed health strategy - Wired-gov.net
Women's voices to be at the heart of renewed health strategy Wired-gov.net
Published: April 15, 2026, 11:14 a.m.
UK Government Launches £1.5M Femtech Challenge Fund as Part of Renewed Women’s Health Strategy - Femtech Insider
UK Government Launches £1.5M Femtech Challenge Fund as Part of Renewed Women’s Health Strategy Femtech Insider
Published: April 15, 2026, 11:04 a.m.
Endometriosis, a 'stumbling block' in the slow progress of women's health - Il Sole 24 ORE
Endometriosis, a 'stumbling block' in the slow progress of women's health Il Sole 24 ORE
Published: April 15, 2026, 10:48 a.m.
LRP1 as a potential diagnostic and immunomodulatory target in endometriosis: evidence from multi-omics and single-cell analyses - Frontiers
LRP1 as a potential diagnostic and immunomodulatory target in endometriosis: evidence from multi-omics and single-cell analyses Frontiers
Published: April 15, 2026, 10:36 a.m.
England Relaunches Women’s Health Strategy Amid “Medical Misogyny” - European Medical Journal
England Relaunches Women’s Health Strategy Amid “Medical Misogyny” European Medical Journal
Published: April 15, 2026, 10:32 a.m.
Link copied to clipboard!